FDA Approval: The FDA granted full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback